APYX - CONSENSUS CO - Apyx Medical

Apyx Medical (APYX) is developing the innovative Renuvion helium plasma-based tissue tightening system, targeting the B2B aesthetic medicine segment. The company is currently focused on independently promoting the method and training physicians, with the indicator standing at 6.60. The price history on the chart below demonstrates the asset's dynamics; however, the business faces severe pressure from laser system manufacturers.

Given the high dependence of demand for Apyx Medical (APYX) equipment on consumer income levels, the consensus price target trajectory serves as an indicator of the asset's expected value amid cyclical volatility. This metric represents the arithmetic mean of target values from industry experts, allowing investors to assess growth potential or overvaluation risk via the gap between the market quote and the fundamental target.